To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Pediatric ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- The pathogenesis of insulin-dependent diabetes mellitus.N Engl J Med. 1994; 331: 1428-1436
- Type I diabetes mellitus: a chronic autoimmune disease.N Engl J Med. 1986; 314: 1360-1368
- Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.Diabetes. 1994; 43: 1304-1310
- Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes.J Autoimmun. 1996; 9: 379-383
- Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies.Diabetes. 1996; 45: 926-933
- Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.J Autoimmun. 1998; 11: 1-10
- Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.Diabetes. 1997; 46: 565-571
- Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.Lancet. 1974; 2: 1279-1283
- Viva ICA: cytoplasmic islet cell antibodies 30 years later [abstract].Diabetes. 2004; 53: A64
- Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus.Diabetologia. 1992; 35: 385-388
- Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes.Diabetes. 1992; 41: 347-353
- Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes.J Clin Invest. 1993; 91: 350-356
- Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase.Diabetes. 1995; 44: 1290-1295
- ICA512 autoantibody radioassay.Diabetes. 1995; 44: 1340-1344
- A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM.Diabetologia. 1994; 37: 344-350
- Insulin antibodies in insulin-dependent diabetics before insulin treatment.Science. 1983; 222: 1337-1339
- A novel micro-assay for insulin autoantibodies.J Autoimmun. 1997; 10: 473-478
- Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay.Diabetologia. 1998; 41: 681-683
- Competitive insulin autoantibody assay: prospective evaluation of subjects at high risk for development of type I diabetes mellitus.Diabetes. 1987; 36: 1286-1291
- Diabetes Antibody Standardization Program: first assay proficiency evaluation.Diabetes. 2003; 52: 1128-1136
- Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers.Diabetes. 1997; 46: 1701-1710
- Evaluation of ICA512As in combination with other islet cell autoantibodies at the onset of IDDM.Diabetes Care. 1997; 20: 1403-1407
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase.Nature. 1990; 347: 151-156
- Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs.Diabetes. 2003; 52: 2689-2695
- High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase.J Mol Biol. 1999; 287: 983-999
- Definition of multiple ICA512/phogrin autoantibody epitopes and detection of intramolecular epitope spreading in relatives of patients with type 1 diabetes.Diabetes. 1998; 47: 733-742
- Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes.Eur J Immunol. 2002; 32: 1420-1427
- Humoral autoimmunity to IA-2 intracellular domain epitopes increases the cumulative risk of type 1 diabetes (T1D) progression [abstract].Diabetes. 2005; : OR121
- Islet cell autoantigen 69 kD (ICA69)L: molecular cloning and characterization of a novel diabetes-associated autoantigen.J Clin Invest. 1993; 92: 359-371
- Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus.Immunol Lett. 2002; 80: 155-162
- A comprehensive guide to antibody and T-cell responses in type 1 diabetes.Tissue Antigens. 2003; 62: 359-377
- Incidence of insulin-dependent diabetes mellitus in Colorado.Epidemiology. 1992; 3: 232-238
- Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.Diabetologia. 1991; 34: 727-733
- A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.N Engl J Med. 1990; 323: 1167-1172
- How, when, and why to predict IDDM.Diabetes. 1988; 37: 1591-1594
- The Pittsburgh Insulin-Dependent Diabetes Mellitus (IDDM) Registries: the descriptive epidemiology of racial differences.in: Mimura G. Clinico-genetic genesis of diabetes mellitus. International Congress Series. Excerpta Medica, Amsterdam, The Netherlands1982: 66-77
- Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren.Diabetologia. 1999; 42: 661-670
- Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study.Diabetes Care. 2002; 25: 505-511
- Beta-cell autoimmunity, genetic susceptibility, and progression to type 1 diabetes in unaffected schoolchildren.Diabetes Care. 2001; 24: 171-173
- Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.J Clin Invest. 1994; 93: 2403-2407
- Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (type 1) diabetes in relatives.J Autoimmun. 1999; 12: 279-287
- Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic parents.Ann Intern Med. 2004; 140: 882-886
- IDDM1 and multiple family history of type 1 diabetes combine to identify neonates at high risk for type 1 diabetes.Diabetes Care. 2004; 27: 2695-2700
- Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.Diabetes. 1998; 47: 1857-1866
- Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes: a population-based study. The Childhood Diabetes in Finland Study Group.J Clin Invest. 1998; 101: 327-336
- Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics.Diabetes. 2004; 53: 384-392
- Risk factors for insulin-dependent diabetes.NIH Publication No. 95–1468. 1995
- Prevalence and incidence of insulin-dependent diabetes.NIH Publication No. 95–1468. 1995
- Type 1 diabetes intervention trials.Pediatr Diabetes. 2001; 2: 2-11
- Risk assessment, prediction and prevention of type 1 diabetes.Pediatr Diabetes. 2001; 2: 71-82
- Major histocompatibility locus and other genes that determine the risk for development of type 1 diabetes mellitus.in: Le Roith D.T. Olefsky J.M. Diabetes mellitus. A fundamental and clinical text. 3rd edition. Lippincott Williams and Wilkins, Philadelphia2004
- The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 caucasian, multiplex families.Am J Hum Genet. 1996; 59: 1134-1148
- Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).Diabetologia. 1996; 39: 807-812
- Panning for gold: genome-wide scanning for linkage in type 1 diabetes.Hum Mol Genet. 1996; 5: 1443-1448
- The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association.Diabetologia. 1983; 24: 224-230
- Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.Proc Natl Acad Sci U S A. 1988; 85: 8111-8115
- Closing in on type 1 diabetes.N Engl J Med. 2001; 345: 1060-1061
- Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.Diabetologia. 2002; 45: 66-76
- Absence of islet autoantibodies at diabetes onset does not rule out type 1A diabetes.Diabetes. 2000; 49: A69
- Autoimmunity and genetics contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers.Am J Epidemiol. 1992; 136: 503-512
- Costs of predicting IDDM.Diabetologia. 1998; 41: 79-85
- Potentials and pitfalls in neonatal screening for type 1 diabetes.Acta Paediatr Suppl. 1999; 88: 80-82
- Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.Diabetes. 1999; 48: 170-175
- High risk DQ alleles improve IDDM prediction in ICA + ve first-degree relatives with decreased insulin secretion [abstract].Diabetologia. 1995; 38: A42
- Autoantibodies to GAD65 and ICA512/IA-2 improve IDDM prediction in first-degree relatives with decreased first phase insulin response and ICA positivity [abstract].Autoimmunity. 1996; 24: 51
- Dual-parameter model for prediction of type I diabetes mellitus.Proc Assoc Am Physicians. 1998; 110: 126-135
- The Melbourne Pre-Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing.Med J Aust. 1998; 169: 81-84
- Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.Diabetologia. 1991; 34: 93-102
- Proposed guidelines on screening for risk of type 1 diabetes.Diabetes Care. 2001; 24: 398
- Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial: a randomized, controlled trial.Ann Intern Med. 1998; 128: 517-523
- Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT).J Clin Endocrinol Metab. 1987; 65: 30-36
- Therapeutic controversy: prevention and treatment of diabetes in children.J Clin Endocrinol Metab. 2000; 85: 494-522
- Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.Diabetes. 1990; 39: 1264-1272
- Cyclosporin-induced remission of IDDM after early intervention: association of 1 yr of cyclosporin treatment with enhanced insulin secretion.Diabetes. 1988; 37: 1574-1582
- Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes.Diabetes. 1989; 38: 779-783
- Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine.Diabetes. 1985; 34: 1306-1308
- Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus.N Engl J Med. 1988; 319: 599-604
- Putative environmental factors in type 1 diabetes.Diabetes Metab Rev. 1998; 14: 31-67
- Environmental factors in the etiology of type 1 diabetes.Am J Med Genet. 2002; 115: 18-29
- Cow's milk exposure and type I diabetes mellitus: a critical overview of the clinical literature.Diabetes Care. 1994; 17: 13-19
- Dietary protein: a trigger of insulin-dependent diabetes in the BB rat?.Diabetologia. 1984; 26: 297-299
- Dietary prevention of diabetes in the non-obese diabetic mouse.Diabetologia. 1988; 31: 62-64
- Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study.Diabetologia. 2005; 48: 829-837
- Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).Diabetologia. 2003; 46: 339-346
- European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.Lancet. 2004; 363: 925-931
- The NOD mouse model of type 1 diabetes: as good as it gets?.Nat Med. 1999; 5: 601-604
- A population based strategy to prevent insulin-dependent diabetes using nicotinamide.J Pediatr Endocrinol Metab. 1996; 9: 501-509
- Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.Proc Natl Acad Sci U S A. 1991; 88: 10252-10256
- Antigen-specific immunotherapy: oral tolerance and subcutaneous immunization in the treatment of insulin-dependent diabetes.Diabetes Metab Rev. 1993; 9: 279-287
- Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats.Diabetologia. 1991; 34: 296-300
- Insulin prophylaxis in individuals at high risk of type I diabetes.Lancet. 1993; 341: 927-928
- Effects of insulin in relatives of patients with type 1 diabetes mellitus.N Engl J Med. 2002; 346: 1685-1691
- The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes.Nat Genet. 1997; 15: 293-297
- Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus.Nat Genet. 1997; 15: 289-292
- Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens.J Immunol. 1998; 161: 5918-5929
- Cellular environment and freedom of gene expression.Nat Immunol. 2002; 3 ([author reply: 336]): 335
- Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs.J Clin Invest. 2001; 107: 555-564
- Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes.Nat Immunol. 2004; 5: 1028-1035
- Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1.Diabetes Care. 2005; 28: 1068-1076
- Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9–23) peptide.Diabetes. 2002; 51: 2126-2134
- C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21–22 October 2001.Diabetes. 2004; 53: 250-264
- Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.Diabetes. 2003; 52: 1059-1065
- CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.J Immunol. 1997; 158: 2947-2954
- Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.Proc Natl Acad Sci U S A. 1994; 91: 123-127
- Mycophenolate mofetil can prevent the development of diabetes in BB rats.Ann N Y Acad Sci. 1993; 696: 328-332
- MMF/DZB study.(Available at:) (Accessed May 12, 2005)
- Immune Tolerance Network. Trial of Thymoglobulin for treatment of new onset type 1 diabetes mellitus.(Available at:) (Accessed May 10, 2005)
- Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial.Lancet. 2001; 358: 1749-1753
- Immunotherapy of insulin-dependent diabetes mellitus.Curr Opin Immunol. 2001; 13: 601-605
- Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.Transplantation. 1999; 68: 608-616
- Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.J Rheumatol. 2002; 29: 1907-1913
- Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.N Engl J Med. 2002; 346: 1692-1698
- Multiple immuno-regulatory defects in type-1 diabetes.J Clin Invest. 2002; 109: 131-140
- CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.J Exp Med. 2001; 193: 1311-1318
- Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.N Engl J Med. 2004; 350: 2572-2581
- Pancreas and islet cell transplantation.Best Pract Res Clin Gastroenterol. 2002; 16: 457-474
- Islet/pancreas transplantation: challenges for pediatrics.Pediatr Diabetes. 2002; 3: 210-223
- Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.N Engl J Med. 2000; 343: 230-238
- Successful islet transplantation: continued insulin reserve provides long-term glycemic control.Diabetes. 2002; 51: 2148-2157
- Regeneration of the pancreatic beta cell.J Clin Invest. 2005; 115: 5-12
- Stem cells and diabetes.Pediatr Diabetes. 2004; 5: 2-4
- Pancreatic stem cells.J Pathol. 2002; 197: 519-526
- Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation.Nature. 2004; 429: 41-46
- Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages.Nat Biotechnol. 2004; 22: 1115-1124
- Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia.Nat Med. 2000; 6: 568-572
- Targeted disruption of the alpha1,3-galactosyltransferase gene in cloned pigs.Nat Biotechnol. 2002; 20: 251-255
- Isolation of the regulatory regions and genomic organization of the porcine alpha1,3-galactosyltransferase gene.Transplantation. 2000; 70: 1275-1283
- Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates.J Biol Chem. 2002; 277: 10114-10120
- Production of alpha 1,3-galactosyltransferase-deficient pigs.Science. 2003; 299: 411-414
- Pancreatic islet transplantation after upper abdominal exenteration and liver replacement.Lancet. 1990; 336: 402-405
- Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes.Cell Transplant. 2002; 11: 113-123
- Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes.Stem Cells. 2003; 21: 377-388
Article info
Footnotes
This work was supported by NIH grants R01 DK53456 and R01 DK56200 (M. Pietropaolo), by NIH R01 DK24021 (M. Trucco), and by an American Diabetes Association Career Development Award (M. Pietropaolo).
Identification
Copyright
© 2005 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
